No products in the cart.
Return To ShopNo products in the cart.
Return To Shop€52.00
ABILIFY 10 mg Bristol – Myers Squibb is a prescription medication that contains aripiprazole as its active ingredient. It is classified as an atypical antipsychotic, primarily known for its application in the treatment of certain mental health disorders. In the realm of sports pharmacology, athletes have increasingly turned to this compound for its potential benefits in enhancing performance. This formulation is designed for oral administration, releasing its active ingredient effectively and providing a concentration that suits various applications within both medical and athletic contexts.
The drug has gained popularity among athletes not only for its potential effects on mood and cognitive function but also for its ability to support their physical efforts during intense training. Notably, ABILIFY has a unique scope of application that extends beyond traditional psychotropic use, making it an interesting choice for performance enhancement.
One of the significant advantages of ABILIFY 10 mg Bristol – Myers Squibb lies in its potential to improve muscle growth along with the enhancement of strength and endurance levels. Athletes often seek ways to maximize gains and mitigate fatigue, and the favorable outcomes associated with this drug can contribute to achieving those goals. By promoting faster recovery times after training sessions, individuals may find themselves able to train more frequently and with higher intensity. Additionally, using this medication can help maintain energy levels and concentration, which is paramount in both training and competitive environments.
For optimal results, it is important to adhere to recommended dosages of ABILIFY 10 mg Bristol – Myers Squibb, which typically fall within a specific range depending on individual needs. The frequency of administration can vary, and players are advised to consult with a knowledgeable healthcare provider. Cycle durations can differ, influenced by an individual’s experience in using performance-enhancing substances, with variations noted between male and female athletes. Each athlete is unique, and an individualized approach ensures that the benefits can be maximized while minimizing potential issues.
As with any pharmacological substance, it is essential to be aware of potential side effects associated with ABILIFY 10 mg Bristol – Myers Squibb. While some users may experience common reactions, such as mild gastrointestinal disturbances or mood fluctuations, these are typically manageable. Respecting recommended dosages and combining it appropriately with other medications is crucial in minimizing risks. Awareness and caution can go a long way in ensuring a safe experience.
When considering the use of ABILIFY 10 mg Bristol – Myers Squibb in conjunction with other substances, it is essential to choose combinations that promote synergistic effects. Typical pairings might include compounds aimed at muscle mass gain, such as anabolic steroids, or those that support strength development. Establishing a balanced approach enables users to not only achieve desired results during the cycle but also sustain the effects once the regimen concludes. Tailoring combinations may lead to enhanced results while preserving health.
ABILIFY 10 mg Bristol – Myers Squibb is available on various websites that offer certified products, ensuring that users can access reliable options with secure ordering processes. These platforms emphasize the importance of quality and safety, providing an ideal avenue for athletes looking to explore this product while maintaining the integrity of their health and performance.
| Raw Material | Aripiprazol |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | Low |
| Lab Test | Monitoring blood levels is not typically required, but lipid profiles, blood glucose, and weight should be monitored |
| Also known as | OPC-14597, OPC-31 |
| Blood pressure | Can cause orthostatic hypotension |
| Trade name | Abilify, Aripiprex |
| Storage conditions | Store at room temperature, 15-30В°C (59-86В°F) |
| Chemical name | 7-{4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one |
| Formula | C23H27Cl2N3O2 |
| Substance class | Atypical antipsychotic |
| Main action | Dopamine D2 and serotonin 5-HT1A receptor partial agonist |
| Half-life | Approximately 75 hours |
| Dosage (medical) | Typically starts at 10-15 mg once daily for schizophrenia, 2-15 mg once daily for bipolar disorder |
| Dosage (sports) | Not applicable |
| Effects | Antipsychotic, mood stabilization, reducing symptoms of schizophrenia and bipolar disorder |
| Side effects | Anxiety, insomnia, nausea, vomiting, blurred vision, somnolence, restlessness, tremor |
| Use in sports | None |
| Manufacturer | Bristol – Myers Squibb |
| Packing | 28 tabs (10 mg/tab) |
€58.00
Reviews
There are no reviews yet.